Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
3 High-Potential Stocks on Track to Double by Next Year
06:26am, Tuesday, 09'th Jul 2024
Building wealth takes time, but if you know where to park your money, you can make the most of your investments. The first half of 2024 was exceptional for the stock market, with several high-pot
3 Undervalued Stocks on Track to Double (or More) by 2028
11:23am, Monday, 08'th Jul 2024
Identifying undervalued growth stocks to buy presents a compelling opportunity for savvy investors. Often overlooked or misunderstood by the broader market, these companies can potentially deliver out
U.S. ETF AUM on Track to Top $10 Trillion in 3 Years
11:41am, Wednesday, 03'rd Jul 2024
The ETF train is well and truly streaming through the countryside, with assets rapidly accumulating for the vehicle. The ETF universe is vast and growing wider at an accelerating rate.
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
08:30am, Tuesday, 02'nd Jul 2024
Agency program will support and expedite clinical studies addressing severe unmet need in children with ABCC6 Deficiency Agency program will support and expedite clinical studies addressing severe unm
3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024
08:30am, Tuesday, 02'nd Jul 2024
Wood added to her positions in Palantir, Archer Aviation, and Intellia Therapeutics on Monday. Palantir is one of her largest holdings, and the big data analytics specialist has more than quadrupled s
Disney Is Back On Track
03:11pm, Monday, 01'st Jul 2024
Disney stock is down after the proxy battle. The pullback offers a bargain opportunity to invest. Movies are back on track after a lackluster year (for Disney). Diversification allows other parts of t
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
01:46pm, Monday, 01'st Jul 2024
Achieve Life Sciences, Inc. initiated an open-label ORCA-OL trial using cytisinicline for smoking cessation; the Efficacy of the drug already established in several prior studies. Alignment with FDA t
3 Breakout Biotech Stocks on Track to Double by 2032
10:02am, Monday, 01'st Jul 2024
With the technology sector taking over in 2024, now is a great time to consider the best breakout biotech stocks to buy. Investing in these companies can be risky yet extremely rewarding, with careful
Gold, Silver, Platinum Forecasts – All On-Track for Quarterly Gains
02:11pm, Friday, 28'th Jun 2024
Gold steadied following a key U.S. inflation report that aligned with expectations, increasing hopes for a Federal Reserve rate cut by September.
Gold, Silver, Platinum Forecasts – All On-Track for Third Quarterly Gain
02:11pm, Friday, 28'th Jun 2024
Gold steadied following a key U.S. inflation report that aligned with expectations, increasing hopes for a Federal Reserve rate cut by September.
Gulfport Energy: 2024 Production On Track Despite Some Deferred Activity
06:09am, Friday, 28'th Jun 2024
Gulfport is now expected to generate close to $300 million in 2024 free cash flow. About three-quarters of this is driven by its hedges. Improved 2025 strip prices point to it potentially being able t
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
04:05pm, Thursday, 27'th Jun 2024
Company Anticipates Completion of Patient Enrollment in the STRIVE-ON Trial in Late 2024 to Early 2025, with Potential NDA Submission on Track for 1H Calendar 2025 Company Anticipates Completion of Pa
Walgreens Shares Crash 24%—On Track For Worst Day Since 1970s
11:08am, Thursday, 27'th Jun 2024
Shares for Walgreens fell over 24% on Thursday, pacing the company's worst loss since at least 1972, after the pharmacy chain announced lower-than-expected quarterly earnings and “significant” sto
EVSM Brings Track Record of Outperformance to ETF Investors
07:12pm, Wednesday, 26'th Jun 2024
The first half of 2024 saw increased mutual fund to ETF conversions. These funds bring the benefits of established track records to ETF investors.
WESTLAKE VILLAGE, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical-stage medical biotechnology company, has completed a $18.5 million financing to support the
